U.S. To Review Chiron's Hepatitis C Patent Deal
The Centers for Disease Control and Prevention is reviewing a 1990 agreement that assigned California biotech company Chiron Corp. exclusive rights to the discovery of hepatitis C in 1987, according to...To view the full article, register now.
Already a subscriber? Click here to view full article